Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00128388 · ClinicalTrials.gov registry record · Phase 2

Psychodynamic Therapy for Treating Panic Disorder

A Phase 2 study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
Phase 2
Development phase
49
Enrollment target

NCT00128388 is a Phase 2 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 49 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00128388, a Phase 2 study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
Phase 2
Development phase
49 participants
Enrollment target

Study Summary

This study will determine the effectiveness of a manualized form of brief psychodynamic psychotherapy in comparison with applied relaxation training in treating adults with panic disorder.

Interventions

  • OTHER ART
  • OTHER PFPP

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2000-02
Est. Completion 2005-07
Phase Phase 2

What the Registry Record Tells You About NCT00128388

The ClinicalTrials.gov registry entry for NCT00128388 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ART is the first listed.

NCT00128388 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00128388 about?

NCT00128388 is a clinical study titled "Psychodynamic Therapy for Treating Panic Disorder". This study will determine the effectiveness of a manualized form of brief psychodynamic psychotherapy in comparison with applied relaxation training in treating adults with panic disorder.

What is the current status of trial NCT00128388?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2000-02. Estimated completion is 2005-07.

What interventions are being tested in trial NCT00128388?

The interventions under investigation include: ART (OTHER), PFPP (OTHER).

Who is sponsoring clinical trial NCT00128388?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.